MDP — Medexus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$129.38m
- CA$144.11m
- $108.33m
Brief: Pediapharm announces global exclusive licensing agreement for Relaxa(R)
Brief: Pediapharm receives Health Canada approval for Rupatadine
Brief: Knight Therapeutics acquires minor stake in Pediapharm
Brief: Pediapharm receives FDA supplement approval regarding Naproxen suspension
Brief: Pediapharm sells its US rights to Naproxen suspension
Brief: Pediapharm acquires the U.S. rights to naproxen suspension